Clinical Trials May Benefit Oncology Patients

Share this content:
Clinical trial participation may yield measurable benefits in terms of costs and extended survival.
Clinical trial participation may yield measurable benefits in terms of costs and extended survival.

Benefits of participating in oncology clinical trials are much greater than previously recognized. Researchers at the Fred Hutchinson Cancer Center in Seattle, Washington, examined the effect of treatment trials on survival of patients with cancer in the US population. They found that there are measurable benefits in terms of costs and extended survival.

For this investigation, the researchers examined how the National Cancer Institute (NCI)-sponsored network cooperative cancer research groups benefited patients with cancer in the general population.  Joseph M. Unger, PhD, MS, and colleagues examined data from 23 positive SWOG treatment trials conducted between 1965 and 2012.  All the calculations were adjusted for age. The US dollar return on investment was estimated as the ratio of the total investment by the NCI in the treatment trial program divided by the estimate of life-years gained.

Estimates of more than 3.34 million life-years were gained through 2015 from the 23 trials. In addition, the return on investment was approximately $125 USD per life-year gained. The researchers concluded that the NCI's investment in its cancer cooperative group research program has provided exceptional value and benefit to the American public. 

Reference

1. Unger JM, LeBlanc M, Blanke CD, et al.  The effect of positive SWOG treatment trials on survival of patients with cancer in the US population [published online June 5, 2017].

JAMA Oncol. doi: 10.1001/jamaoncol.2017.0762
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs